Unlike the wild-type KIT whose activation needs ligand binding, the gain-of-function mutations of KIT that occur in GISTs and other malignancies such as mastocytosis confer the ligand-independent activation to the receptor, leading to uncontrolled signaling and eventually cell transformation [21, 22]. This evidence concerns the gene KIT and mastocytosis.